Exploring the inflammatory pathophysiology in eosinophilic COPD – is there a role for precision medicine?

October 10, 2023 from 9:45 am 10:30 am HST

Supported By: GSK

Program Description

The role of inflammatory mediators and biomarkers, particularly eosinophils, is evolving in chronic obstructive pulmonary disease (COPD). This program will explore the pathophysiology of the inflammatory pathways of COPD, the role of eosinophils in airway inflammation, and highlight the impact of exacerbations on disease progression.

This is a non-CME event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2023 conference sessions. This event is not endorsed by CHEST and does not reflect the views or opinions of CHEST.


Frank C. Sciurba, MD, FCCP
University of Pittsburgh Medical Center
Pulmonary, Allergy and Critical Care Medicine
Professor of Medicine and Education
Pittsburgh, PA